Optimal control and cost-effectiveness analysis for the human melioidosis model

Akanni "Modelling financial crime population dynamics: optimal control and cost-effectiveness analysis" Int. J. Dyn. Control (2020) 10.1007/s40435-019-00572-3

[3]

Aldila "Optimal control problem and backward bifurcation on malaria transmission with vector bias" Heliyon (2021) 10.1016/j.heliyon.2021.e06824

[4]

Ali "Molecular detection of leptospirosis and melioidosis co-infection: a case report" J. Infect. Public Health (2017) 10.1016/j.jiph.2017.02.009

[5]

Ansari (2014)

[6]

Asamoah "Optimal control and comprehensive cost-effectiveness analysis for covid-19" Results Phys. (2022) 10.1016/j.rinp.2022.105177

[7]

Aziz "Comparative genomics confirms a rare melioidosis human-to-human transmission event and reveals incorrect phylogenomic reconstruction due to polyclonality" Microb. Genomics (2020) 10.1099/mgen.0.000326

[8]

Benoit "Melioidosis cases and selected reports of occupational exposures to burkholderia pseudomallei—United States, 2008–2013" Morb. Mortal. Wkly. Rep., Surveill. Summ. (2015)

[9]

Chakravorty "Melioidosis: an updated review" Aust. J. Gen. Pract. (2019) 10.31128/ajgp-04-18-4558

[10]

Chowdhury "The epidemiology of melioidosis and its association with diabetes mellitus: a systematic review and meta-analysis" Pathog. (2022) 10.3390/pathogens11020149

[11]

Currie "A global picture of melioidosis" Nature (2016) 10.1038/529290a

[12]

Treatment and prophylaxis of melioidosis

David Dance

International Journal of Antimicrobial Agents 2014 10.1016/j.ijantimicag.2014.01.005

[13]

Dutta "Antimicrobial susceptibility pattern of clinical isolates of burkholderia pseudomallei in Bangladesh" BMC Res. Notes (2017) 10.1186/s13104-017-2626-5

[14]

Engida "A mathematical model analysis of the human melioidosis transmission dynamics with an asymptomatic case" Heliyon (2022) 10.1016/j.heliyon.2022.e11720

[15]

Engida "Optimal control and cost-effectiveness analysis for leptospirosis epidemic" J. Biol. Dyn. (2023) 10.1080/17513758.2023.2248178

[16]

Fen "Antibiotic susceptibility of clinical burkholderia pseudomallei isolates in northeast Thailand during 2015-2018 and the genomic characterization of β-lactam-resistant isolates" Antimicrob. Agents Chemother. (2021)

[17]

Fleming "Applications of mathematics" (1975)

[18]

Ghosh "Mathematical analysis of reinfection and relapse in malaria dynamics" Appl. Math. Comput. (2020)

[19]

Heesterbeek "Modeling infectious disease dynamics in the complex landscape of global health" Science (2015) 10.1126/science.aaa4339

[20]

The Mathematics of Infectious Diseases

Herbert W. Hethcote

SIAM Review 2000 10.1137/s0036144500371907

[21]

Panduka "Melioidosis: clinical aspects" Clin. Med. (2022) 10.7861/clinmed.2022-0014

[22]

Karunarathna "A case report of melioidosis complicated by infective sacroiliitis in Sri Lanka" Trop. Dis. Travel Med. Vaccines (2018) 10.1186/s40794-018-0073-5

[23]

Kingsley "Pitfalls and optimal approaches to diagnose melioidosis" Asian Pac. J. Trop. Med. (2016) 10.1016/j.apjtm.2016.04.003

[24]

Kumar "Vaccination and treatment as control interventions in an infectious disease model with their cost optimization" Commun. Nonlinear Sci. Numer. Simul. (2017) 10.1016/j.cnsns.2016.08.005

[25]

Lamba "Cost-effective optimal control analysis of a covid-19 transmission model incorporating community awareness and waning immunity" Comput. Math. Biophys. (2023) 10.1515/cmb-2023-0154

[26]

Lenhart (2007)

[27]

Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis

Direk Limmathurotsakul, Nick Golding, David A. B. Dance et al.

Nature Microbiology 2016 10.1038/nmicrobiol.2015.8

[28]

Luangasanatip "The global impact and cost-effectiveness of a melioidosis vaccine" BMC Med. (2019) 10.1186/s12916-019-1358-x

[29]

Mahikul "Modelling population dynamics and seasonal movement to assess and predict the burden of melioidosis" PLoS Negl. Trop. Dis. (2019) 10.1371/journal.pntd.0007380

[30]

Mohapatra "Burden of melioidosis in India and south Asia: challenges and ways forward" (2022)

[31]

Okyere "Analysis of Zika virus dynamics with sexual transmission route using multiple optimal controls" Sci. Afr. (2020)

[32]

Olaniyi "Modelling malaria dynamics with partial immunity and protected travellers: optimal control and cost-effectiveness analysis" J. Biol. Dyn. (2020) 10.1080/17513758.2020.1722265

[33]

Olaniyi "Global stability and optimal control analysis of malaria dynamics in the presence of human travelers" Open Inf. Dis. J. (2018)

[34]

Modeling SARS-CoV-2 and HBV co-dynamics with optimal control

Andrew Omame, Mujahid Abbas

Physica A: Statistical Mechanics and its Applicati... 2023 10.1016/j.physa.2023.128607

[35]

Omame "Backward bifurcation and optimal control in a co-infection model for sars-cov-2 and zikv" Results Phys. (2022) 10.1016/j.rinp.2022.105481

[36]

Phillips "Melioidosis in a patient with chronic rhinosinusitis" J. Laryngol. Otolog (2016) 10.1017/s0022215116008276

[37]

Pontryagin (1962)

[38]

Romero-Leiton "An optimal control problem applied to malaria disease in Colombia" Appl. Math. Sci. (2018)

[39]

Ross "Evaluating new compounds to treat burkholderia pseudomallei infections" Front. Cell. Infect. Microbiol. (2018) 10.3389/fcimb.2018.00210

[40]

Sharomi "Optimal control in epidemiology" Ann. Oper. Res. (2017) 10.1007/s10479-015-1834-4

[41]

Singh "Melioidosis: the great mimicker" J. Commun. Hosp. Int. Med. Perspect. (2017)

[42]

Srivastava "Nonlinear dynamics of a siri model incorporating the impact of information and saturated treatment with optimal control" Eur. Phys. J. Plus (2022) 10.1140/epjp/s13360-022-03201-9

[43]

Sun (2006)

[44]

Tavaen "Global stability and optimal control of melioidosis transmission model with hygiene care and treatment" Int. J. Sci. (2019)

[45]

Terefe "Analysis of a mathematical model for the transmission dynamics of human melioidosis" Int. J. Biomath. (2020) 10.1142/s179352452050062x

[46]

Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission

P. van den Driessche, James Watmough

Mathematical Biosciences 2002 10.1016/s0025-5564(02)00108-6

[47]

Wiersinga "Melioidosis" Nat. Rev. Dis. Primers (2018) 10.1038/nrdp.2017.107

Metrics

12

Citations

47

References

Details

Published: Feb 01, 2024
Vol/Issue: 10(4)
Pages: e26487
License: View

Authors

H

Habtamu Ayalew Engida

Cite This Article

Habtamu Ayalew Engida, Duncan Kioi Gathungu, Melkamu Molla Ferede, et al. (2024). Optimal control and cost-effectiveness analysis for the human melioidosis model. Heliyon, 10(4), e26487. https://doi.org/10.1016/j.heliyon.2024.e26487

Optimal control and cost-effectiveness analysis for the human melioidosis model

You May Also Like